SAN DIEGO, March 02, 2026 (GLOBE NEWSWIRE) — Johnson Fistel, PLLP is investigating potential claims on behalf of investors of Elevance Health, Inc. (NYSE: ELV). The investigation focuses on whether Elevance and its executive officers complied with federal securities laws.
What if I purchased Elevance securities?
If you purchased Elevance securities and suffered losses on your investment, join our investigation now: Click here to join the investigation.
Or for more information, contact Jim Baker at jimb@johnsonfistel.com or (619) 814-4471.
There is no cost or obligation to you.
Background of the Investigation
On February 27, 2026, Elevance filed a Form 8-K disclosing that the Centers for Medicare & Medicaid Services notified the Company of its intent to impose intermediate sanctions suspending enrollment into certain Medicare Advantage-Prescription Drug plans and suspending certain communications to Medicare beneficiaries. The sanctions are scheduled to take effect March 31, 2026 unless CMS determines the issues have been satisfactorily addressed.
In light of this disclosure, Johnson Fistel is investigating whether Elevance complied with the federal securities laws. If you suffered losses from your investment in Elevance stock, contact Johnson Fistel.
About Johnson Fistel, PLLP | Securities Fraud & Investor Rights
Johnson Fistel, PLLP is a nationally recognized shareholder-rights law firm with offices in California, New York, Georgia, Idaho, and Colorado. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits and also assists foreign investors who purchased shares on U.S. exchanges. To learn more, visit www.johnsonfistel.com.
Attorney advertising.
Past results do not guarantee future outcomes.
Services may be performed by attorneys in any of our offices.
Johnson Fistel, PLLP has paid for the dissemination of this promotional communication, and Frank J. Johnson is the attorney responsible for its content.
Contact
Johnson Fistel, PLLP
501 W. Broadway, Suite 800
San Diego, CA 92101
James Baker, Investor Relations – or – Frank J. Johnson, Esq.
(619) 814-4471 | jimb@johnsonfistel.com | fjohnson@johnsonfistel.com
